SK285358B6 - Spôsob prípravy farmaceutickej formulácie obsahujúcej peptidovú zlúčeninu a nosnú makromolekulu a farmaceutická kompozícia obsahujúca ich soľ - Google Patents
Spôsob prípravy farmaceutickej formulácie obsahujúcej peptidovú zlúčeninu a nosnú makromolekulu a farmaceutická kompozícia obsahujúca ich soľ Download PDFInfo
- Publication number
- SK285358B6 SK285358B6 SK1131-2001A SK11312001A SK285358B6 SK 285358 B6 SK285358 B6 SK 285358B6 SK 11312001 A SK11312001 A SK 11312001A SK 285358 B6 SK285358 B6 SK 285358B6
- Authority
- SK
- Slovakia
- Prior art keywords
- pharmaceutical composition
- peptide compound
- ionic
- carrier macromolecule
- peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11907699P | 1999-02-08 | 1999-02-08 | |
| PCT/EP2000/000697 WO2000047234A1 (fr) | 1999-02-08 | 2000-01-29 | Sels d'agents pharmaceutiques a liberation prolongee et leur production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK11312001A3 SK11312001A3 (sk) | 2002-04-04 |
| SK285358B6 true SK285358B6 (sk) | 2006-11-03 |
Family
ID=22382454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1131-2001A SK285358B6 (sk) | 1999-02-08 | 2000-01-29 | Spôsob prípravy farmaceutickej formulácie obsahujúcej peptidovú zlúčeninu a nosnú makromolekulu a farmaceutická kompozícia obsahujúca ich soľ |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1150717B1 (fr) |
| JP (1) | JP2002536421A (fr) |
| KR (1) | KR100661768B1 (fr) |
| CN (1) | CN1203897C (fr) |
| AR (1) | AR022537A1 (fr) |
| AT (1) | ATE298252T1 (fr) |
| AU (1) | AU768882B2 (fr) |
| BG (1) | BG65581B1 (fr) |
| BR (1) | BR0008786A (fr) |
| CA (1) | CA2360110C (fr) |
| CO (1) | CO5160256A1 (fr) |
| CZ (1) | CZ20012841A3 (fr) |
| DE (1) | DE60020939T2 (fr) |
| DK (1) | DK1150717T3 (fr) |
| ES (1) | ES2242601T3 (fr) |
| HK (1) | HK1044719B (fr) |
| HU (1) | HUP0200127A3 (fr) |
| IL (2) | IL144739A0 (fr) |
| MX (1) | MXPA01007983A (fr) |
| NO (1) | NO20013851L (fr) |
| NZ (1) | NZ513748A (fr) |
| PL (1) | PL196094B1 (fr) |
| PT (1) | PT1150717E (fr) |
| RU (1) | RU2239457C2 (fr) |
| SI (1) | SI1150717T1 (fr) |
| SK (1) | SK285358B6 (fr) |
| TR (1) | TR200102289T2 (fr) |
| TW (1) | TWI237568B (fr) |
| UA (1) | UA72502C2 (fr) |
| WO (1) | WO2000047234A1 (fr) |
| ZA (1) | ZA200106467B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100452752B1 (ko) * | 2000-04-18 | 2004-10-12 | 주식회사 펩트론 | 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제 |
| US7098305B2 (en) * | 2001-09-06 | 2006-08-29 | Ardana Bioscience Limited | Sustained release of microcrystalline peptide suspensions |
| US6818613B2 (en) | 2001-11-07 | 2004-11-16 | Ortho-Mcneil Pharmaceutical, Inc. | Aqueous sustained-release formulations of proteins |
| US7214662B2 (en) | 2001-11-27 | 2007-05-08 | Zentaris Gmbh | Injectable solution of an LHRH antagonist |
| US7884071B2 (en) * | 2002-09-27 | 2011-02-08 | Zentaris Gmbh | Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| EP1674082A1 (fr) * | 2004-12-22 | 2006-06-28 | Zentaris GmbH | Procédé pour la manufacture des suspensions ou lyophilisates steriles des complexes mal-soluble de peptides basic, des formulations pharmaceutiques avec ces complexes et leur utilisation comme medicament |
| CN105878174B (zh) * | 2016-04-26 | 2021-06-29 | 广州帝奇医药技术有限公司 | 一种固体分散体及其制备方法与应用 |
| CN113368041B (zh) * | 2020-07-17 | 2023-01-03 | 丽珠医药集团股份有限公司 | 药物组合物、缓释制剂及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4581169A (en) * | 1982-12-21 | 1986-04-08 | Syntex (U.S.A.) Inc. | Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists |
| GB9211268D0 (en) * | 1992-05-28 | 1992-07-15 | Ici Plc | Salts of basic peptides with carboxyterminated polyesters |
| CA2178592C (fr) * | 1993-12-09 | 2009-07-28 | Jurgen Engel | Suspensions pour injection a action prolongee et procede de preparation |
| US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| AU5678398A (en) * | 1997-01-29 | 1998-08-18 | Takeda Chemical Industries Ltd. | Sustained-release microspheres, their production and use |
| DE19712718C2 (de) * | 1997-03-26 | 1999-09-23 | Asta Medica Ag | Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung |
-
2000
- 2000-01-28 CO CO00005024A patent/CO5160256A1/es unknown
- 2000-01-29 TR TR2001/02289T patent/TR200102289T2/xx unknown
- 2000-01-29 BR BR0008786-6A patent/BR0008786A/pt not_active IP Right Cessation
- 2000-01-29 CN CNB008048177A patent/CN1203897C/zh not_active Expired - Fee Related
- 2000-01-29 UA UA2001096159A patent/UA72502C2/uk unknown
- 2000-01-29 AU AU27997/00A patent/AU768882B2/en not_active Ceased
- 2000-01-29 NZ NZ513748A patent/NZ513748A/en not_active IP Right Cessation
- 2000-01-29 AT AT00906245T patent/ATE298252T1/de not_active IP Right Cessation
- 2000-01-29 PT PT00906245T patent/PT1150717E/pt unknown
- 2000-01-29 EP EP00906245A patent/EP1150717B1/fr not_active Expired - Lifetime
- 2000-01-29 HU HU0200127A patent/HUP0200127A3/hu unknown
- 2000-01-29 ES ES00906245T patent/ES2242601T3/es not_active Expired - Lifetime
- 2000-01-29 SI SI200030705T patent/SI1150717T1/xx unknown
- 2000-01-29 JP JP2000598185A patent/JP2002536421A/ja active Pending
- 2000-01-29 MX MXPA01007983A patent/MXPA01007983A/es active IP Right Grant
- 2000-01-29 CA CA002360110A patent/CA2360110C/fr not_active Expired - Fee Related
- 2000-01-29 SK SK1131-2001A patent/SK285358B6/sk unknown
- 2000-01-29 PL PL350054A patent/PL196094B1/pl not_active IP Right Cessation
- 2000-01-29 RU RU2001125033/15A patent/RU2239457C2/ru not_active IP Right Cessation
- 2000-01-29 DE DE60020939T patent/DE60020939T2/de not_active Expired - Lifetime
- 2000-01-29 IL IL14473900A patent/IL144739A0/xx unknown
- 2000-01-29 DK DK00906245T patent/DK1150717T3/da active
- 2000-01-29 CZ CZ20012841A patent/CZ20012841A3/cs unknown
- 2000-01-29 KR KR1020017009966A patent/KR100661768B1/ko not_active IP Right Cessation
- 2000-01-29 WO PCT/EP2000/000697 patent/WO2000047234A1/fr active IP Right Grant
- 2000-01-31 TW TW089101652A patent/TWI237568B/zh not_active IP Right Cessation
- 2000-02-08 AR ARP000100535A patent/AR022537A1/es unknown
-
2001
- 2001-08-06 IL IL144739A patent/IL144739A/en not_active IP Right Cessation
- 2001-08-07 NO NO20013851A patent/NO20013851L/no not_active Application Discontinuation
- 2001-08-07 ZA ZA200106467A patent/ZA200106467B/en unknown
- 2001-09-01 BG BG105864A patent/BG65581B1/bg unknown
-
2002
- 2002-08-29 HK HK02106380.3A patent/HK1044719B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5757686B2 (ja) | 微晶質ペプチド懸濁液の徐放性 | |
| EP1028746B1 (fr) | Procede de production de formulations d'igf-1 a liberation echelonnee | |
| NO338309B1 (no) | Farmasøytisk gel-preparat, fremgangsmåte for fremstilling og kitt, samt anvendelsen av det farmasøytiske gel-preparatet for fremstilling av et medikament | |
| JPH08507064A (ja) | 有機溶媒を用いて処理したポリペプチドの賦形剤安定化 | |
| JP4180120B2 (ja) | Ｌｈｒｈ−アンタゴニストの固定化及び活性安定化複合体及びその製法 | |
| AU7404101A (en) | Pharmaceutical form of administration for peptides, methods for its production and use | |
| EP1150717B1 (fr) | Sels d'agents pharmaceutiques a liberation prolongee et leur production | |
| KR20030046413A (ko) | 펩타이드 염의 제조방법, 이의 용도 및 이들 펩타이드염을 함유하는 약제학적 제제 |